News from the healthcare data industry
TUESDAY NOVEMBER 9TH, 2021 Amongst vaccinated Americans, Moderna recipients experience most adverse events and Johnson & Johnson recipients have most hospitalizations REDMOND, Wash. – November 9, 2021 – Truveta, the...
CAMBRIDGE, Mass. and DURHAM, N.C., Nov. 9, 2021 /PRNewswire/ — ConcertAI, LLC (ConcertAI), a leader in enterprise AI and RWD solutions for life science companies and healthcare providers, announced today the integration of TeraRecon as...
Kronos Bio, Inc. (Nasdaq: KRON), a company dedicated to transforming the lives of those affected by cancer, and Tempus, a leader in artificial intelligence and precision medicine, today announced a...
BOSTON, Nov. 5, 2021 /PRNewswire/ — Analysis Group, a global leader in health economics and outcomes research (HEOR) and regulatory epidemiology, today announced the publication of research examining the US Food and Drug...
NEW YORK & DENVER–(BUSINESS WIRE)–AlixPartners, the global consulting firm, and Palantir Technologies, a leading builder of operating systems for the modern enterprise, today announced a strategic partnership designed to unlock...
Tempus Labs Inc., a precision medicine startup led by a Groupon Inc. co-founder, is exploring a U.S. initial public offering, according to people with knowledge of the matter. The Chicago-based company is...
DEVON, Penn., Nov. 2, 2021 — COEUS Holdings and its subsidiaries, together a leading health outcomes, contracting and commercial insights consulting firm, today announced a strategic partnership with Datavant, the leader in privacy-compliant...
SAN FRANCISCO and SAN DIEGO, Nov. 01, 2021 (GLOBE NEWSWIRE) — Kinnate Biopharma Inc. (Nasdaq: KNTE) (“Kinnate”), a biopharmaceutical company focused on the discovery and development of small molecule kinase...
Cambridge, MA, November 1, 2021 — TriNetX, the global network of healthcare organizations driving real-world research to accelerate the development of new therapies, has announced that Jeffrey Brown, PhD, is joining...
DUBLIN, Ohio, Oct. 28, 2021 /PRNewswire/ — Cardinal Health (NYSE: CAH) announced today it has been awarded a $750,000 contract by the U.S. Food and Drug Administration (FDA) to implement an 18-month real world evidence (RWE)...